Topic: Neurodegenerative Disorders

« Back Print this page

  Personalized Program
The Personalized Program enables you to compile an individual program with events and contributions of your interest. Therefore, it can be used very well to plan your actual congress visit at an early point of time. Please log in to use the Personalized Program.
» Login
» Identification
» Help
   
No. P-05 - Poster Presentation
Time: 12.30-14.00
Room: Foyer
Topic: Neurodegenerative Disorders
Session title: Neurodegenerative Disorders I
  Alexandre Dailliet, Belgium Chair
     
001 Regular moderate physical exercise improves mood and quality of life in older patients with atrial fibrillation  
  Christine Norra, Germany Presenter
002 EEG complexity in Alzheimer’s disease: Multiscale entropy analysis  
  Tomoyuki Mizuno, Japan Presenter
003 Rivastigmine and behavioral disorder of the patients in the centers for old persons  
  Aleksandar Miljatovic, Serbia and Montenegro Presenter
004 Cerebrolysin in the treatment of dementia mixed type and Alzheimer’s disease  
  Andreea Silvana Szalontay, Romania Presenter
005 Safety, efficacy, and biomarker findings of PBT2 in targeting ?-amyloid as a modifying therapy for Alzheimer's disease: A phase IIa, double-blind, randomised, placebo-controlled trial  
  Olivia Dean, Australia Presenter
006 The implication of oxidative stress in a rat model of Parkinson's disease  
  Ciobica Alin, Romania Presenter
008 Crime or illness? The mystery of Frontotemporal Dementias  
  Franziskos Xepapadakos, Switzerland Presenter
009 Donepezil reverses beta-amyloid-induced deficits in long term potentiation in rat hippocampal slices  
  Elena Solntseva, Russia Presenter
010 Benefit of analyzing biological markers in cerebrospinal fluid in diagnosing Alzheimer’s during a consultation with an expert from a Centre Mémoire de Ressources et de Recherche  
  Danièle Bentué-Ferrer, France Presenter
011 Effects of apolipoprotein E genotype on behavioral and psychological symptoms in Alzheimer’s disease  
  Shin-Gyeom Kim, Korea, Republic of Presenter
013 Examining gene-gene interactions between tau haplotypes and ApoE4 in Alzheimer’s disease  
  Péter Álmos, Hungary Presenter
014 Creutzfeldt-Jakob dementia and psychiatric symptoms  
  José de Santiago Sastre, Spain Presenter
015 Symptomatic treatment of delirium  
  José de Santiago Sastre, Spain Presenter
016 Classifying what? How dementia classifications shape the concept of “normal” aging  
  Lara Katharina Kutschenko, Germany Presenter
017 Inflammatory biomarkers in Alheimer’s Disease: Clinical correlates  
  Anton Alvarez, Spain Presenter
018 Dementia caused by Sanfilippo B syndrome  
  Willem Verhoeven, Netherlands Presenter
019 Pharmacotherapy in intellectual disabilities  
  Willem Verhoeven, Netherlands Presenter
020 White matter lesions in Korsakoff syndrome  
  Willem Verhoeven, Netherlands Presenter
     
No. S-19 - Symposium
Time: 14.00-15.30
Room: Room 351
Topic: Neurodegenerative Disorders
Track: 2 Clinical
Session title: Early diagnosis of Alzheimers disease
  Bruno Dubois, France Chair
  Harald Hampel, Germany Co-Chair
     
No. TG-02 - WFSBP Treatment Guidelines
Time: 16.00-17.30
Room: Room 242A
Topic: Neurodegenerative Disorders
Session title: Psychogeriatrics
  Cornelius Katona, United Kingdom Chair
     
  Constantine Lyketsos, USA Presenter
  Claudia Cooper, United Kingdom Presenter
  Carlos Augusto de Mendonca Lima, Portugal Presenter
  Gill Livingston, United Kingdom Presenter
No. FC-09 - Free Communications
Time: 08.00-09.30
Room: Room 242B
Topic: Neurodegenerative Disorders
Session title: Neurodegenerative Disorders
  Cornelius Katona, United Kingdom Chair
  Anne Eckert, Switzerland Co-Chair
     
No. S-32 - Symposium
Time: 11.00-12.30
Room: Salle Maillot
Topic: Neurodegenerative Disorders
Track: 3 Interface
Session title: Depression and dementia: Stress hormones and neuroprotection
  Edith Holsboer-Trachsler, Switzerland Chair
  Luc Staner, France Co-Chair
     
No. S-42 - Symposium
Time: 16.00-17.30
Room: Room 251
Topic: Neurodegenerative Disorders
Track: 1 Basic
Session title: Neurobiology of Alzheimer's disease: Beyond the amyloid hypothesis
  Orestes V. Forlenza, Brazil Chair
  Russell H. Swerdlow, USA Co-Chair
     
001 Alzheimer's disease, vascular dementia, or both?  
  Donald R. Royall, USA Speaker
002 The GSK-3 hypothesis of Alzheimer's disease  
  Simon Lovestone, United Kingdom Speaker
003 Phospholipids, phospholipase A2 and membrane abnormalities in Alzheimer's disease  
  Wagner F. Gattaz, Brazil Speaker
004 Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?  
  Russell H. Swerdlow, USA Speaker
No. S-52 - Symposium
Time: 11.00-12.30
Room: Room 241
Topic: Neurodegenerative Disorders
Track: 3 Interface
Session title: Clinical and biological aspect of apathy in neuropsychiatry
  Philippe Robert, France Chair
  Albert Leentjens, Netherlands Co-Chair
     
No. P-24 - Poster Presentation
Time: 12.30-14.00
Room: Foyer
Topic: Neurodegenerative Disorders
Session title: Neurodegenerative Disorders II
  Serge Gauthier, Canada Chair
     
001 Peculiarities and treatment of delirium in geriatrics patients with traumatic injuries  
  Liubov Romasenko, Russia Presenter
002 Effects of glycine on learning, memory ability and hippocampal gene expression of APP, PS1, BACE in rats with Alzheimer disease  
  Bai Han, China, People's Republic of Presenter
003 Study on Chinese herb Danshen-Dahuang on learning, memory ability and hippocampal Tau and Aß in rats with Alzheimer disease  
  Bai Han, China, People's Republic of Presenter
004 The study on the level of intestinal endotoxemia in Alzheimer’s disease rats  
  Bai Han, China, People's Republic of Presenter
005 Amisulpride in the treatment of very late onset schizophrenia  
  Constantin Psarros, Greece Presenter
007 Behavior and attention disorders at the children with intellectual disabilities  
  Dragana Macesic-Petrovic, Serbia and Montenegro Presenter
008 Age-dependent induction of neurofibrillary tangles in transgenic mice overexpressing a non-mutant human tau isoform  
  Etsuko Oshima, Japan Presenter
009 Exploratory efficacy in cross-maze test depends on neurochemical profile of brain  
  Georgy Kovalev, Russia Presenter
010 Enhancing resilience to stress and quality of life in depressed family dementia caregivers: A randomized placebo-controlled trial of escitalopram  
  Helen Lavretsky, USA Presenter
012 Comparison of frontotemporal dementia and healthy volunteers using quantative EEG  
  Keiichiro Nishida, Japan Presenter
013 The role of oxidative stress in Mild Cognitive Impairment and Alzheimer disease  
  Manuela Padurariu, Romania Presenter
014 Creatine deficiency syndrome: Study of a cohort of 530 patients in the CHU of Rouen  
  Marc Chévrier, France Presenter
015 Persistence of abnormal cortisol levels in elderly persons after recovery from major depression  
  Marie Laure Ancelin, France Presenter
016 Tactile perception in children with intellectual disabilities  
  Mirjana Japundza-Milisavljevic, Serbia and Montenegro Presenter
017 Depression in Parkinson’s disease: Serotonin mechanisms, response to SSRI antidepressants  
  Natalya Demchuk, Russia Presenter
018 Copper binding effect on amyloid peptide aggregation in Alzheimer's disease  
  Nuria Durany, Spain Presenter
019 Memory performance in patients with obstructive sleep apnea before and after positive airway pressure  
  Perbal Séverine, France Presenter
020 Psychosis in Parkinson’s disease patients: The relevance of dopaminergic drugs and of their mode of application  
  Ronald Saurugg, Austria Presenter
021 Switching strategy involving Galantamine in the treatment of patients with mild to moderate Alzheimers disease  
  Tae-Young Hwang, Korea, Republic of Presenter
     
No. S-54 - Symposium
Time: 16.00-17.30
Room: Blue Amphitheatre
Topic: Neurodegenerative Disorders
Track: 1 Basic
Session title: Aß Immunotherapy of Alzheimer's disease
  Siegfried Kasper, Austria Chair
  Serge Gauthier, Canada Co-Chair
     
001 Selection of efficacy outcomes in disease-modifying trials that are meaningful to clinicians, patients and payers  
  Serge Gauthier, Canada Speaker
002 Biomarkers in Alzheimer's disease: Use for clinical trials  
  Anton Alvarez, Spain Speaker
003 AD vaccines: The new generation - successes and challenges on its way into clinical practice  
  Achim Schneeberger, Austria Speaker
004 AFFITOPES of Aß as active vaccines in the treatment of AD: results of a phase I study with AFFITOPE AD02  
  Alexandra Kutzelnigg, Austria Speaker
No. S-62 - Symposium
Time: 08.00-09.30
Room: Room 352AB
Topic: Neurodegenerative Disorders
Track: 2 Clinical
Session title: Lithium, neuroprotection and dementia
  Wagner F. Gattaz, Brazil Chair
  Husseini Manji, USA Co-Chair